Metformin Aging Study to Assess Insulin Sensitivity and Mitochondrial Function
A 12-week double-blind, placebo-controlled trial will evaluate metformin's effects on insulin sensitivity and mitochondrial function in aging individuals.
Therapeutic Area
Therapeutic area intelligence for Metformin with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.